SOURCE: DC Brands International, Inc.

December 19, 2007 11:47 ET

DC Brands Q1 Inventory in Production

DENVER, CO--(Marketwire - December 19, 2007) - DC Brands International (PINKSHEETS: DCBR) announces that two members of their team, Jeremy Alcamo and Chris McVicker, will be traveling to Wisconsin today to oversee production of the company's Turn Left and Dickens Energy Cider inventory for Q1 2008.

"This is one of our largest runs ever, and the great news is that it is already more than 65 percent sold in January and February due to normal sell through rates," said DC Brands Chief Operating Officer Keith Howard. "We also have significant commitments from the new distributors and retailers our VP of Sales Jim Randall and his team have lined up. Immediately after the holidays, our team will return to oversee the production of the initial run of the first seven formulas of the all-new Fahrenheit Fitness products. We sent draft samples of that product to all of our shareholders in the past six weeks and in that time have made all the necessary tweaks and corrections to the labels and packaging -- it really is an impressive product line."

About DC Brands International:

DC Brands International, a publicly traded company under the ticker symbol (PINKSHEETS: DCBR), specializes in and manufactures unique energy drink brands. Established in 1998, DC Brands went public in 2005, and the company's first product, Dickens Energy Cider, launched in 2002 after a lengthy process in developing its distinctive flavor and packaging. Following the success of Dickens Energy Cider, the company chose to expand its product line with a beverage that filled the substantial NASCAR niche. With more than 75 million loyal fans, the NASCAR demographic presented an attractive opportunity to become one of the few racecar-themed energy drinks in the marketplace. Following much due diligence, research and testing, Turn Left Energy Drink recently came to fruition.

For more information on DC Brands International, visit their website at and

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information